← Back to Search

Proton Pump Inhibitor

Secretol for Heartburn

Phase 1 & 2
Waitlist Available
Led By Ronnie Fass, MD
Research Sponsored by Effexus Pharmaceutical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks of treatment
Awards & highlights

Study Summary

To compare the complete healing of erosive esophagitis(EE) after 3 weeks of treatment with Secretol 80/80 versus Nexium 40 mg daily.

Eligible Conditions
  • Heartburn
  • Acid Reflux
  • Indigestion

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary objective is to evaluate the relationship between healing and study drug allotment.

Trial Design

2Treatment groups
Active Control
Group I: SecretolActive Control1 Intervention
Comparing the efficacy of 80/80 Secretol once daily in healing erosive esophagitis.
Group II: NexiumActive Control1 Intervention
Comparing 40 mg.once daily in healing erosive esophagitis.

Find a Location

Who is running the clinical trial?

Southern Arizona VA Health Care SystemFED
10 Previous Clinical Trials
868 Total Patients Enrolled
Effexus PharmaceuticalLead Sponsor
2 Previous Clinical Trials
18 Total Patients Enrolled
Ronnie Fass, MDPrincipal InvestigatorSouthern Arizona VA Health Care System
10 Previous Clinical Trials
379 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025